UT Health San Antonio gains $2M to study rapamycin for Alzheimer’s

DeStrider · 2022-12-07T00:37:02.417Z

It’s a step in the right direction.

UT Health San Antonio gains $2M to study rapamycin for Alzheimer’s - UT...

In the war on cancer and other diseases including COVID-19, old drugs approved for other conditions are being studied for new purposes. It’s a strategy that will now be tested in Alzheimer’s disease with a drug called rapamycin. A $2 million grant...

Est. reading time: 6 minutes